257 related articles for article (PubMed ID: 38491228)
21. Sinonasal Adenosquamous Carcinoma - Morphology and Genetic Drivers Including Low- and High-Risk Human Papillomavirus mRNA, DEK::AFF2 Fusion, and MAML2 Rearrangement.
Holliday D; Mehrad M; Ely KA; Tong F; Wang X; Hang JF; Kuo YJ; Velez-Torres JM; Lott-Limbach A; Lewis JS
Head Neck Pathol; 2023 Jun; 17(2):487-497. PubMed ID: 36849671
[TBL] [Abstract][Full Text] [Related]
22. Spindle Cell Tumors of the Sinonasal Tract: A Diagnostic Update with Focus on Ancillary Workup.
Almohsen SS; Demicco EG
Head Neck Pathol; 2024 Feb; 18(1):8. PubMed ID: 38363429
[TBL] [Abstract][Full Text] [Related]
23. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
Kezlarian BE; Lin O; Dogan S
J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
[TBL] [Abstract][Full Text] [Related]
24. Top 10 Significant Spindled Head and Neck Lesions to Scrutinze.
Udager AM
Head Neck Pathol; 2023 Mar; 17(1):132-142. PubMed ID: 36928738
[TBL] [Abstract][Full Text] [Related]
25. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract][Full Text] [Related]
26. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
[TBL] [Abstract][Full Text] [Related]
27. Proceedings of the 2023 North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Navigating New Developments in High Grade Sinonasal Neuroendocrine and Neuroectodermal Neoplasms.
Rooper LM
Head Neck Pathol; 2023 Jun; 17(2):299-312. PubMed ID: 37184733
[TBL] [Abstract][Full Text] [Related]
28. Update from the 5th Edition of the WHO Classification of Nasal, Paranasal, and Skull Base Tumors: Imaging Overview with Histopathologic and Genetic Correlation.
Agarwal A; Bhatt AA; Bathla G; Kanekar S; Soni N; Murray J; Vijay K; Vibhute P; Rhyner PH
AJNR Am J Neuroradiol; 2023 Oct; 44(10):1116-1125. PubMed ID: 37591773
[TBL] [Abstract][Full Text] [Related]
29. A diagnostic algorithm for sinonasal papillary non-keratinizing squamous cell carcinoma with DEK::AFF2 fusion and mimickers.
Laforga JB; Othman BK
Rev Esp Patol; 2024; 57(1):67-70. PubMed ID: 38246714
[TBL] [Abstract][Full Text] [Related]
30. Clinical management of emerging sinonasal malignancies.
Contrera KJ; Woody NM; Rahman M; Sindwani R; Burkey BB
Head Neck; 2020 Aug; 42(8):2202-2212. PubMed ID: 32212360
[TBL] [Abstract][Full Text] [Related]
31. [Sinonasal tumors : News from the WHO with special reference to mesenchymal entities].
Agaimy A; Haller F; Hartmann A
Pathologe; 2018 Feb; 39(1):18-26. PubMed ID: 29396607
[TBL] [Abstract][Full Text] [Related]
32. Recently described neoplasms of the sinonasal tract.
Bishop JA
Semin Diagn Pathol; 2016 Mar; 33(2):62-70. PubMed ID: 26776744
[TBL] [Abstract][Full Text] [Related]
33. Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications.
Xu B; Aryeequaye R; Wang L; Katabi N
Head Neck Pathol; 2018 Jun; 12(2):274-278. PubMed ID: 28980201
[TBL] [Abstract][Full Text] [Related]
34. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma.
Dieter SM; Heining C; Agaimy A; Huebschmann D; Bonekamp D; Hutter B; Ehrenberg KR; Fröhlich M; Schlesner M; Scholl C; Schlemmer HP; Wolf S; Mavratzas A; Jung CS; Gröschel S; von Kalle C; Eils R; Brors B; Penzel R; Kriegsmann M; Reuss DE; Schirmacher P; Stenzinger A; Federspil PA; Weichert W; Glimm H; Fröhling S
Ann Oncol; 2017 Jan; 28(1):142-148. PubMed ID: 27687311
[TBL] [Abstract][Full Text] [Related]
35. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base.
Stelow EB; Bishop JA
Head Neck Pathol; 2017 Mar; 11(1):3-15. PubMed ID: 28247233
[TBL] [Abstract][Full Text] [Related]
36. Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies.
Miller DL; Palsgrove DN; Rijal A; Hathuc V; Chernock R; Gagan J; Bishop JA
Head Neck Pathol; 2022 Sep; 16(3):928-933. PubMed ID: 35218513
[TBL] [Abstract][Full Text] [Related]
37. Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature.
Crocetta FM; Botti C; Fornaciari M; Castellucci A; Murri D; Santandrea G; Piana S; Ghidini A
Head Neck Pathol; 2021 Dec; 15(4):1409-1414. PubMed ID: 33686584
[TBL] [Abstract][Full Text] [Related]
38. Differentiated Papillary NUT Carcinoma: An Unexpected, Deceptively Bland Presentation of a Sinonasal Carcinoma.
Wartenberg M; Hool SL; Marrazzini A; Giger R; Rupp NJ
Head Neck Pathol; 2023 Sep; 17(3):803-807. PubMed ID: 37118352
[TBL] [Abstract][Full Text] [Related]
39. Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity.
Andreasen S; Bishop JA; Hellquist H; Hunt J; Kiss K; Rinaldo A; Skálová A; Willems SM; Williams M; Ferlito A
Virchows Arch; 2018 Nov; 473(5):615-626. PubMed ID: 30109475
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Molecular Profiling of Sinonasal Teratocarcinosarcoma Highlights Recurrent SMARCA4 Inactivation and CTNNB1 Mutations.
Rooper LM; Agaimy A; Gagan J; Simpson RHW; Thompson LDR; Trzcinska AM; Ud Din N; Bishop JA
Am J Surg Pathol; 2023 Feb; 47(2):224-233. PubMed ID: 36206446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
